Harmony Biosciences Makes The Grade
Source: SeekingAlpha
2026-02-02 15:47:26 ET
Today, I am putting Harmony Biosciences Holdings, Inc. ( HRMY ) in the spotlight for the first time since my last article of this reasonable valued biopharma firm back in June of last year. The stock has moved up slightly since that research was posted and made a good covered call trade as was the recommendation then. The company's revenues rose nearly 30% on a year-over-year basis on its last posted quarterly results and management boosted guidance slightly meriting another look. An updated analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Harmony Biosciences Makes The Grade
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
-0.63% G/L:
$18.115 Last:
1,281,262 Volume:
$18.15 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
